Work

Predictors of Vedolizumab Dose Escalation or Cessation in Inflammatory Bowel Disease Patients

Year: 2017

Type: article

Study design: Observational Study

Source: The American Journal of Gastroenterology

DOI: 10.14309/00000434-201710001-00749

Authors: Mohammed A. Razvi, Reezwana Chowdhury, Alyssa Parian, Joanna Melia, Brindusa Truta, Steve Brant, Sharon Dudley-Brown, Mark Lazarev

Institution: Johns Hopkins University

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2912682385

FWCI:

Cites:

Cited by:

Related to: 10